VerImmune Revenue and Competitors
Estimated Revenue & Valuation
- VerImmune's estimated annual revenue is currently $852.5k per year.
- VerImmune's estimated revenue per employee is $65,577
Employee Data
- VerImmune has 13 Employees.
- VerImmune grew their employee count by 30% last year.
VerImmune's People
Name | Title | Email/Phone |
---|---|---|
1 | Founding CEO & President | Reveal Email/Phone |
2 | Associate Scientist I (Preclinical process development) | Reveal Email/Phone |
3 | Scientist, Non-clinical | Reveal Email/Phone |
4 | Executive Business Advisor | Reveal Email/Phone |
VerImmune Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 35 | 0% | N/A | N/A |
#2 | $1.2M | 6 | -14% | N/A | N/A |
#3 | $13.6M | 88 | 4% | N/A | N/A |
#4 | $1.1M | 7 | 40% | N/A | N/A |
#5 | $0.9M | 13 | 30% | N/A | N/A |
#6 | $5.1M | 33 | 3% | N/A | N/A |
#7 | $132.5M | 855 | 6% | N/A | N/A |
#8 | N/A | 4 | 300% | N/A | N/A |
#9 | $0.9M | 6 | 0% | N/A | N/A |
#10 | $0.6M | 4 | -20% | N/A | N/A |
What Is VerImmune?
VerImmune is advancing Anti-tumor Immune Redirection (AIR): A Breakthrough Therapy that Redirects Pre-Existing Immune Memory from Childhood Vaccination or Infection to Fight Cancer
keywords:N/AN/A
Total Funding
13
Number of Employees
$852.5k
Revenue (est)
30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 13 | N/A | N/A |
#2 | $3.5M | 13 | 0% | N/A |
#3 | $2M | 13 | 0% | N/A |
#4 | $1.6M | 13 | -7% | N/A |
#5 | $1.6M | 13 | -24% | N/A |